211 related articles for article (PubMed ID: 25268196)
1. Clear cell melanoma: a cutaneous clear cell malignancy.
Pletneva MA; Andea A; Palanisamy N; Betz BL; Carskadon S; Wang M; Patel RM; Fullen DR; Harms PW
Arch Pathol Lab Med; 2014 Oct; 138(10):1328-36. PubMed ID: 25268196
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
[TBL] [Abstract][Full Text] [Related]
3. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.
Ferenczi K; Lastra RR; Farkas T; Elenitsas R; Xu X; Roberts S; Brooks JS; Zhang PJ
Int J Surg Pathol; 2012 Feb; 20(1):29-36. PubMed ID: 21903680
[TBL] [Abstract][Full Text] [Related]
4. Superficial paramucosal clear cell sarcoma of the soft parts resembling melanoma in a 13-year-old boy.
Sidiropoulos M; Busam K; Guitart J; Laskin WB; Wagner AM; Gerami P
J Cutan Pathol; 2013 Feb; 40(2):265-8. PubMed ID: 23228147
[TBL] [Abstract][Full Text] [Related]
5. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
Panagopoulos I; Mertens F; Isaksson M; Mandahl N
Cancer Genet Cytogenet; 2005 Jan; 156(1):74-6. PubMed ID: 15588860
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous perivascular epithelioid cell tumor: a clinicopathological and molecular reappraisal.
Charli-Joseph Y; Saggini A; Vemula S; Weier J; Mirza S; LeBoit PE
J Am Acad Dermatol; 2014 Dec; 71(6):1127-36. PubMed ID: 25267378
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma.
Falconieri G; Bacchi CE; Luzar B
Am J Dermatopathol; 2012 Aug; 34(6):619-25. PubMed ID: 22421295
[TBL] [Abstract][Full Text] [Related]
8. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
10. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
13. [Primary cutaneous perivascular epithelioid cell tumor: report of a case].
Zhang Y; Sui Y; Tu J; Cui H; Chen F; Hou Y; Feng Y
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):280-1. PubMed ID: 24915824
[No Abstract] [Full Text] [Related]
14. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
[TBL] [Abstract][Full Text] [Related]
15. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
16. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
[TBL] [Abstract][Full Text] [Related]
17. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
18. Clear cell variant of malignant melanoma of the uterine cervix: a case report and review of the literature.
Furuya M; Shimizu M; Nishihara H; Ito T; Sakuragi N; Ishikura H; Yoshiki T
Gynecol Oncol; 2001 Mar; 80(3):409-12. PubMed ID: 11263942
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.
Wagner BP; Epperla N; Medina-Flores R
Diagn Pathol; 2013 Nov; 8():192. PubMed ID: 24274261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
